alexa Serum Thyrotropin Concentration as a Predictor of Malignancy in Thyroid Follicular Neoplasm | OMICS International
ISSN: 2167-7948

Journal of Thyroid Disorders & Therapy
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Editorial

Serum Thyrotropin Concentration as a Predictor of Malignancy in Thyroid Follicular Neoplasm

Seyyed Morteza Taghavi* and Reyhaneth Takallu
Endocrine research centre, Massad Medical university, Iran
Corresponding Author : Seyyed Morteza Taghavi
Endocrinologist, Assistant professor of Endocrinology
Endocrine research centre, Massad Medical university
Ahmad Abad Street, Ghaem Hospital, Mashhad, Iran
Tel: 00989155164037
Fax:00985118406757
E-mail: [email protected]
Received October 15, 2012; Accepted October 18, 2012; Published October 21, 2012
Citation: Taghavi SM, Takallu R (2012) Serum Thyrotropin Concentration as a Predictor of Malignancy in Thyroid Follicular Neoplasm. Thyroid Disorders Ther 1:e106. doi:10.4172/2167-7948.1000e106
Copyright: © 2012 Taghavi SM, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Abstract

Abstract
Objective: The clinical importance of thyroid nodules is the need to exclude thyroid malignancy, and fine-needle
aspiration biopsy (FNAB) is the current gold standard for the evaluation of thyroid nodules. The main limitation of
FNAB is follicular neoplasm. Follicular thyroid carcinoma differentiates less frequently with FNAB from microfollicular
or cellular adenomas. Serum TSH is introduced recently as a useful marker for predicting malignancy in a thyroid
nodule. The main aim of our study was the evaluation of this correlation in patients with thyroid nodule with cytology
reports of follicular neoplasm, in them the final diagnosis of benign or malignant disease confirmed histologically after
surgery.
Method: We prospectively collected data on 75 patients including 64 females and 11 males presenting with
thyroid nodule with cytology report of follicular neoplasm. A primary evaluation was performed at presentation
through measurement of T4, T3, and TSH concentrations and thyroid radioisotope scan. A final histological diagnosis
was made in all patients after thyroid surgery. The influence of factors including age, gender, size and location of
nodules, and serum TSH concentration on the final diagnostic outcome was investigated statistically.
Results: In 42 patients (56%), the nodule was on right lobe, in 30 patients (40%), the nodule was on left lobe
and in 3 patients (4%), on isthmus. Mean age was 37.6 ± 11.36 (15-68) years. Mean size of nodules was 18.4 ±
17.48 mm. Mean TSH was 0.9 ± 1.29 mU/liter. After surgery, malignancy was confirmed in 19 (25.3%) patients. In
38 patients (50.7%), final pathology was follicular adenoma and in 18 (24%), it was multinodular goiter. There was
no correlation between sex, age, size and location of nodule and malignancy. Mean TSH was significantly higher in
cancer patients.
Conclusion: The serum TSH concentration at presentation is an independent predictor of the presence of
thyroid malignancy in patients with follicular neoplasm.

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri & Aquaculture Journals

Dr. Krish

[email protected]

1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

 
© 2008- 2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version